IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court.
Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 76,000-strong team delivers world-class excellence every day, within and beyond our 190 healthcare facilities, including 89 hospitals.
Within Malaysia, IHH operates 18 hospitals with approximately 3,600 beds under trusted brands including Gleneagles, Island Hospital, Pantai, Prince Court and Timberland Medical Centre. Supported by ancillary services such as Premier Integrated Labs, Premier Integrated Rehab and primary care clinics under Twin Towers Medical Centre, our more than 15,000 staff and 2,000 consultants deliver comprehensive care across the healthcare continuum, from primary and ambulatory to tertiary and quaternary services, complemented by diagnostics and rehabilitation.
In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network.
www.ihhhealthcare.com
Our CEO
Lim Kooi Ling
Chief Executive Officer,
Gleneagles Hospital Penang
Lim Kooi Ling is the Chief Executive Officer of Gleneagles Hospital Penang, where she drives the hospital’s commitment to patient-centred care. She leads efforts to strengthen clinical and operational excellence, ensuring a trusted healthcare experience for patients.
She has 24 years’ experience in the healthcare industry, with a significant 15 years at Island Hospital. In 2022, she was appointed Chief of Staff with oversight for the hospital’s strategic development and quality assurance programmes, aligning them closely with long-term goals for sustainable growth and exceptional care. Lim was promoted to Chief Executive Officer in 2024.
Prior to that, Lim was Director of Medical Services where she was instrumental in managing the hospital’s specialty development and regulatory affairs, ensuring high standards across its medical practices while driving the hospital’s capacity expansion and growth in clinical services. An optometrist with a double Masters in Business Administration and Law, she began her career in the allied health sciences before joining Island Hospital in 2009 as a Pharmacy Manager.
In 2019, Lim received the prestigious Johnson & Johnson Trust’s grant for INSEAD’s Innovating Healthcare for Tomorrow, being the only Malaysian achieving this certification. She is widely published in the field of optometry with numerous international publications and book chapters in corneal topography and wavefront aberrometry between 2009 to 2013.